Rapigen is a global in-vitro diagnostics (IVD) company specializing in the development and manufacturing of in-vitro diagnostic medical devices and molecular diagnostic products. We provide fast and accurate diagnostic solutions based on immunoassay and molecular diagnostic technologies.

Our main product portfolio includes rapid diagnostic test (RDT) kits, molecular diagnostic reagents, and molecular diagnostic kits. Rapigen offers diagnostic solutions for a wide range of diseases, including malaria, dengue, HIV, respiratory infections (COVID-19, influenza, RSV, etc.), women’s health (pregnancy and ovulation tests), and gastrointestinal diseases (Helicobacter pylori, fecal occult blood tests).

To enhance the convenience and accessibility of our products, we are integrating diagnostic solution equipment and continuously investing in research and development to improve the usability of high-reliability IVD products.